WPD Pharmaceuticals Inc.

    WPD Pharmaceuticals Inc.

    CCSE:WBIO
    - -
    CAD
    - -
    - -
    WPD Pharmaceuticals Inc.
    CSE:WBIO
    (Canadian Securities Exchange)

    Recent

    price

    - -

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    2008
    2009
    2010
    2011
    2012
    2013
    2014
    2015
    2016
    2017
    2018
    2019
    2019
    2020
    2022
    2023
    TTM
    CAD
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Revenue per Share
    -0.02
    -2.13
    -3.83
    -2.55
    -1.68
    -1.06
    -1.07
    -0.55
    -0.2
    -1.87
    -1.76
    -0.91
    -84.99
    - -
    0.85
    -0.02
    - -
    Basic EPS, GAAP
    -0.01
    -1.27
    -2.73
    -2.61
    -1.32
    -0.94
    -1.12
    -0.2
    - -
    -0.66
    -3.08
    -0.9
    -1.72
    - -
    -0.76
    -0.05
    -0.04
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Dividend per Share
    5.16
    7.77
    5.75
    3.4
    2.02
    1.06
    -0.02
    -0.31
    -0.51
    -2.32
    0.44
    0.76
    0.72
    0.24
    -0.11
    -0.12
    -0.13
    Book Value per Share
    5.16
    7.77
    5.75
    3.4
    2.02
    1.06
    -0.02
    -0.31
    -0.51
    -2.32
    0.44
    0.76
    0.65
    0.1
    -0.11
    -0.12
    -0.13
    Tangible Book Value per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    1
    - -
    - -
    5
    5
    5
    Basic Weighted Avg Shares
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Sales/Revenue/Turnover
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Operating Margin (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Depreciation Expense
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    -1
    -12
    - -
    4
    - -
    - -
    Net Income, GAAP
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    - -
    1
    1
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    1
    2
    - -
    - -
    - -
    - -
    Working Capital
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    LT Debt
    - -
    1
    1
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    1
    3
    1
    - -
    -1
    -1
    Total Equity
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    1,081.72
    - -
    -13.26
    Return on Capital (%)
    - -
    -29.79
    -54.03
    -55.68
    -62.03
    -68.76
    - -
    - -
    - -
    - -
    - -
    -121.3
    -555.43
    - -
    - -
    - -
    - -
    Return on Common Equity (%)

    Capital Structure

    CAD

    •

    in mil. unless spec.
    Mar'24
    Jun'24
    Sep'24
    ST Debt
    - -
    - -
    - -
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    5
    5
    5
    Market Capitalization
    5
    2
    1

    Working Capital

    CAD

    •

    in mil. unless spec.
    Mar'24
    Jun'24
    Sep'24
    Total Current Assets
    - -
    - -
    - -
    Cash, Cash Equivalents & STI
    - -
    - -
    - -
    Accounts Receivable, Net
    - -
    - -
    - -
    Inventories
    - -
    - -
    - -
    Total Current Liabilities
    1
    1
    1
    Payables & Accruals
    1
    1
    1
    ST Debt
    - -
    - -
    - -
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    CAD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    220.81%
    49.95%
    16.12%
    Free Cash Flow
    - -
    - -
    -94.08%
    Net Income, GAAP
    - -
    - -
    -102.08%
    Sales/Revenue/Turnover
    - -
    - -
    - -
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    -0.13
    -0.18
    -0.2
    - -
    0.85
    2023
    -0.01
    -0.02
    -0.02
    - -
    -0.02
    2024
    -0.03
    - -
    0.01
    - -
    - -

    Quarterly Dividends Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business